Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Filings indexed 1,740 across all filing types
Latest filing 2022-11-08 Regulatory Filings
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
111年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, Hua Guang, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, management discussion, or regulatory certifications. The content is concise and factual, typical of a regulatory announcement or compliance disclosure rather than a full report or detailed financial filing. Given the short length (601 characters) and the nature of the data, it fits best as a Regulatory Filing (RNS), which serves as a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-08 Chinese
111年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings and pledged shares by insiders, including directors, supervisors, and senior management of the company 華廣生技股份有限公司. It lists share counts, pledged shares, and related party holdings. The document is focused on insider shareholdings and pledges rather than financial results, management changes, or voting outcomes. It does not contain financial statements or earnings data, nor does it announce a report or meeting results. The content matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives.
2022-11-07 Chinese
111年10月內部人持股異動(事後)
Major Shareholding Notification Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties, with specific numbers of shares held, changes in holdings, and classifications of shares. The content focuses on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of financial statements, earnings data, or meeting results. The document is a regulatory disclosure of insider shareholdings, which aligns with the category of Major Shareholding Notification (MRQ). The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the best fitting classification is MRQ.
2022-11-07 Chinese
111年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of it being a full financial report, earnings release, or regulatory announcement of a report. The document is not a proxy statement or voting results announcement. It is a detailed insider shareholding disclosure, which corresponds to the category of Director's Dealing (DIRS).
2022-10-14 Chinese
111年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, independent directors, general manager, and other executives. It lists their shareholdings, pledged shares, and related percentages. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and pledges, which aligns with reporting on insider transactions or director dealings. Given the nature of the data focusing on insider shareholdings and pledges, the most appropriate classification is Director's Dealing (DIRS). The document length is 3230 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2022-10-14 Chinese
111年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (華廣) providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing rather than a full financial report or announcement. The document is short (601 characters) and contains tabular data on financial guarantees but no comprehensive financial statements or management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) as it is a routine compliance disclosure without detailed financial analysis or report publication.
2022-10-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.